Universal Display to Acquire Merck OLED Patent Assets

Reuters
Nov 07, 2025
Universal Display to Acquire Merck OLED Patent Assets

Universal Display Corporation is set to acquire a portfolio of emissive OLED patent assets from Merck KGaA, Darmstadt, Germany. The transaction will involve UDC Ireland Limited, a wholly owned subsidiary of Universal Display Corporation, and is expected to close in January 2026, subject to customary conditions. The portfolio includes more than 300 issued and pending patents across over 110 unique patent families, with an average remaining lifetime of about 10 years. These assets cover advanced OLED emissive device structures and related material components, expanding Universal Display Corporation's patent coverage in high-efficiency OLED technologies. The move aligns with Merck's strategy to focus on charge transport and triplet host materials, enhancing the performance of components surrounding emissive materials in OLED devices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Universal Display Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20251106101217) on November 06, 2025, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10